Bustamante, Jhan G.
HRN: 23-24-90 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/25/2023
08/31/2023
IV
320mg
Q8
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes